ProfileGDS4718 / 1560908_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 53% 50% 51% 51% 53% 54% 54% 50% 52% 52% 51% 50% 50% 51% 53% 49% 50% 54% 56% 61% 49% 49% 51% 50% 51% 53% 52% 60% 54% 57% 51% 52% 51% 51% 50% 51% 57% 52% 49% 50% 50% 54% 51% 51% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.6643353
GSM549102patient 115, normal, homogenized [OPG study]5.5403650
GSM549104patient 119, normal, homogenized [OPG study]5.5865851
GSM549108patient 138, normal, homogenized [OPG study]5.5951151
GSM549119patient 077, normal, homogenized [OPG study]5.6761653
GSM549133patient 032, cancer, homogenized [OPG study]5.706754
GSM549139patient 042, cancer, homogenized [OPG study]5.7286354
GSM549099patient 107, normal, homogenized [OPG study]5.5025450
GSM549109patient 139, normal, homogenized [OPG study]5.6636952
GSM549110patient 046, normal, homogenized [OPG study]5.6088252
GSM549114patient 063, normal, homogenized [OPG study]5.547551
GSM549122patient 082, normal, homogenized [OPG study]5.5447450
GSM549134patient 033, cancer, homogenized [OPG study]5.4891750
GSM549136patient 036, cancer, homogenized [OPG study]5.5499851
GSM549140patient 044, cancer, homogenized [OPG study]5.6815853
GSM549111patient 047, normal, homogenized [OPG study]5.46549
GSM549113patient 057, normal, homogenized [OPG study]5.4391550
GSM549132patient 031, cancer, homogenized [OPG study]5.7511654
GSM549137patient 038, cancer, homogenized [OPG study]5.8462756
GSM549142patient 047, cancer, homogenized [OPG study]6.2687961
GSM549100patient 110, normal, homogenized [OPG study]5.484949
GSM549107patient 135, normal, homogenized [OPG study]5.4403949
GSM549115patient 068, normal, homogenized [OPG study]5.5442651
GSM549116patient 072, normal, homogenized [OPG study]5.4998150
GSM549120patient 078, normal, homogenized [OPG study]5.5857351
GSM549131patient 030, cancer, homogenized [OPG study]5.6691253
GSM549118patient 074, normal, homogenized [OPG study]5.6340452
GSM549129patient 027, cancer, homogenized [OPG study]6.1859260
GSM549123patient 088, normal, homogenized [OPG study]5.720754
GSM549124patient 006, cancer, homogenized [OPG study]5.9612157
GSM549126patient 015, cancer, homogenized [OPG study]5.5403351
GSM549128patient 025, cancer, homogenized [OPG study]5.5957852
GSM549103patient 117, normal, homogenized [OPG study]5.5958451
GSM549117patient 073, normal, homogenized [OPG study]5.5484151
GSM549138patient 041, cancer, homogenized [OPG study]5.4795550
GSM549141patient 045, cancer, homogenized [OPG study]5.5164151
GSM549130patient 028, cancer, homogenized [OPG study]5.9293557
GSM549101patient 111, normal, homogenized [OPG study]5.628752
GSM549105patient 128, normal, homogenized [OPG study]5.4642949
GSM549106patient 134, normal, homogenized [OPG study]5.4674950
GSM549112patient 048, normal, homogenized [OPG study]5.5335850
GSM549125patient 011, cancer, homogenized [OPG study]5.7642454
GSM549127patient 024, cancer, homogenized [OPG study]5.6175251
GSM549135patient 035, cancer, homogenized [OPG study]5.5156651